Search research articles
Contact Us
Filters
Showing results (61-70 of 135) with videos related to
Page
of 14
Sort By:
Breast Cancer Research and Treatment
|
March 16, 2006
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52
James N Ingle, Vera J Suman, James A Mailliard, et al.
ISRN Oncology
|
April 23, 2013
Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer
Jennifer L Peterson, Steven J Buskirk, Michael G Heckman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2006
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Deborah A Kuban, Larry B Levy, Louis Potters, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 13, 2024
Five-Year Outcomes of Moderately Hypofractionated Proton Therapy Incorporating Elective Pelvic Nodal Irradiation for High-Risk Prostate Cancer
Richard Choo, David W Hillman, Cecilia Mitchell, et al.
Urologic Oncology
|
May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapy
Robert T Dess, Payal D Soni, William C Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2006
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
Michael J Zelefsky, Deborah A Kuban, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2009
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer
Alexander S Parker, Michael G Heckman, Kevin J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
Michael E Ray, Howard D Thames, Larry B Levy, et al.
Cancer
|
September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
Eric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2007
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
Mary Feng, Alexandra L Hanlon, Thomas M Pisansky, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 135) with videos related to
Sort By:
Page
of 14
Breast Cancer Research and Treatment
|
March 16, 2006
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52
James N Ingle, Vera J Suman, James A Mailliard, et al.
ISRN Oncology
|
April 23, 2013
Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer
Jennifer L Peterson, Steven J Buskirk, Michael G Heckman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2006
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Deborah A Kuban, Larry B Levy, Louis Potters, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 13, 2024
Five-Year Outcomes of Moderately Hypofractionated Proton Therapy Incorporating Elective Pelvic Nodal Irradiation for High-Risk Prostate Cancer
Richard Choo, David W Hillman, Cecilia Mitchell, et al.
Urologic Oncology
|
May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapy
Robert T Dess, Payal D Soni, William C Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2006
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
Michael J Zelefsky, Deborah A Kuban, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2009
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer
Alexander S Parker, Michael G Heckman, Kevin J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
Michael E Ray, Howard D Thames, Larry B Levy, et al.
Cancer
|
September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
Eric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2007
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
Mary Feng, Alexandra L Hanlon, Thomas M Pisansky, et al.
Page
of 14